Linda Horspool

Dr. Linda Horspool


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
TNT. Nell
T. Nell
JBJ. Bergman
J. Bergman
MHM. Hoeijmakers
M. Hoeijmakers
PLP. Van Laar
P. Van Laar
LHLinda Horspool
Linda Horspool

1 October 2008 in Journal of Feline Medicine and Surgery
Verified
Journal Article
Closed access
LMLaurence Michiels
Laurence Michiels
CRClaudia E. Reusch
Claudia E. Reusch
ABAndrea Boari
Andrea Boari
GPGrant Petrie
Grant Petrie
Paul J. J. MandigersPaul J. J. Mandigers
Paul J. J. Mandigers
LHLinda Horspool
Linda Horspool
This prospective, multicentre, non-blinded, open study followed 46 cats with diabetes mellitus during treatment with porcine lente insulin (also known as porcine insulin zinc suspension, Caninsulin®, Intervet) for 16±1 weeks (stabilization phase), with additional monitoring of some cats ( n=23) for a variable period. At least three of the following were present at initial presentation: appropriate history of clinical signs consistent with diabetes mellitus, glucosuria, blood glucose greater than 15 mmol/l and fructosamine greater than 380 μmol/l. Insulin treatment was started at a dose rate of 0.25–0.5 IU/kg body weight twice daily, with a maximum starting dose of 2 IU/injection. Twenty-eight of the cats were classed as reaching clinical stability during the study, in 23 of these cats this was during the stabilization phase. Seven cats went into remission during the stabilization phase and one of the cats in week 56. Clinical signs of hypoglycaemia, significantly associated with a dose of 3 units or 0.5 IU/kg or more per cat (twice daily), were observed in nine of the 46 cats during the stabilization phase and concomitant biochemical hypoglycaemia was recorded in most cases. Biochemical hypoglycaemia, recorded in 6% of the blood glucose curves performed during the stabilization phase, was significantly associated with a dose rate of 0.75 IU/kg or more twice daily. This further highlights the need for cautious stepwise changes in insulin dose. The protocol used in the present study is suitable for and easy to use in practice. This study confirmed the efficacy and safety of porcine lente insulin (Caninsulin®) in diabetic cats under field conditions.


31 December 1995 in British Veterinary Journal
Verified
Journal Article
Closed access
LHLinda Horspool
Linda Horspool
QMQ.A. McKellar
Q.A. McKellar

1 July 1990 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
LHLinda Horspool
Linda Horspool
QMQ. A. McKELLAR
Q. A. McKELLAR

1 October 2009 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
RFR. Frénais
R. Frénais
DRD. Rosenberg
D. Rosenberg
SBS. Burgaud
S. Burgaud
LHLinda Horspool
Linda Horspool